您好,欢迎来到科研在线!科研采购 · 选型 · 实验方法
首页产品库品牌馆产品类别品牌新闻会议会展产品试用求职招聘资讯专题教程
PRO / Antibodies

Anti-Human CD7 Antibody

Anti-Human CD7 Antibody

英诺赛图(InnoCyto)的 Anti-Human CD7 Antibody(克隆 Grisnilimab) 为人源 IgG1 单克隆抗体,靶向 CD7(别名 gp40),Purified 标记,适用于流式细胞术。提供 25 μg、100 μg 规格,目录价 ¥475 起,仅供科研使用(RUO)。

生物试剂 供应商 上海英诺赛图 ↗ 型号 118801 更新 2026-11-12
参考价格区间
¥475
含税参考价,实际以配置与渠道报价为准
本条目供应商 上海英诺赛图原厂 1865个条目 进入企业主页

01产品图片

02产品简介

英诺赛图(InnoCyto)的 Anti-Human CD7 Antibody(克隆 Grisnilimab) 为人源 IgG1 单克隆抗体,靶向 CD7(别名 gp40),Purified 标记,适用于流式细胞术。提供 25 μg、100 μg 规格,目录价 ¥475 起,仅供科研使用(RUO)。

03产品介绍

规格与货号

118801 | 25 μg | ¥475

118802 | 100 μg | ¥680

Product Details

Regulatory Status|RUO

Protein Concentration|0.5 mg/mL

Storage & Handling|The antibody solution should be stored between 2°C and 8°C

Recommended Usage|For flow cytometric staining, it is recommended to use less than 0.2 µg of this reagent per 0.5-1.0 million cells in a 100 µL volume. Optimal reagent performance should be determined by titration for each specific application

See All Formats|Clone Grisnilimab

Background Information

Human CD7 is a 40-kDa type I transmembrane glycoprotein and one of the earliest surface markers expressed during T-cell development. It is present on the majority of mature T cells and natural killer (NK) cells, as well as on early lymphoid and some myeloid progenitors. CD7 belongs to the immunoglobulin superfamily and contains a single extracellular immunoglobulin-like domain, a transmembrane region, and a short cytoplasmic tail containing signaling motifs. CD7 contributes to T-cell and NK-cell activation, adhesion, and cytokine production, functioning primarily as a costimulatory molecule that can amplify signals generated through the T-cell receptor.

The best-characterized ligand for human CD7 is secreted and transmembrane protein 1 (SECTM1), which exists in both membrane-bound and soluble forms. Interaction between SECTM1 and CD7 can promote T-cell proliferation and enhance cytokine production, including interferon-γ and IL-2, particularly in cooperation with other costimulatory signals.

CD7 itself is not generally considered a disease-causing molecule, but its expression pattern makes it an important biomarker and therapeutic target in hematological malignancies. CD7 is expressed in more than 95% of T-cell acute lymphoblastic leukemia (T-ALL) and T-cell lymphoblastic lymphoma (T-LBL), and is also present in subsets of peripheral T-cell lymphomas and acute myeloid leukemia.

Therapeutically, CD7 is being extensively investigated as a target for monoclonal antibodies, antibody-drug conjugates, immunotoxins, and particularly CAR-T-cell therapy. CD7 CAR-T cells have shown promising responses in relapsed or refractory T-ALL/LBL and other CD7-positive malignancies. A major challenge is “fratricide,” because normal T cells and the engineered CAR-T cells themselves express CD7. Gene editing, protein masking, and other engineering strategies are therefore being developed to prevent CAR-T self-killing and improve treatment durability.

Data Sheets

Human peripheral blood lymphocytes were stained with PB Anti-Human CD3 clone UCHT1 and Purified Anti-Human CD7 biosimilar Grisnilimab (left) or an isotype control (right), followed by PE Anti-Human IgG.

04完整参数表

参数由厂商资料整理,采购前请以最终报价单与技术协议为准。

包装规格25 μg
CloneGrisnilimab
ApplicationFlow Cytometry
ReactivityHuman
FormatPurified
Target NameCD7, gp40
IsotypeHuman IgG1
Antibody TypeMonoclonal
Regulatory StatusRUO
FormulationPhosphate-buffered solution, pH 7.2, containing 0.09% sodium azide
Protein Concentration0.5 mg/mL
目录价¥475

05荣誉与资质

该品牌暂未上传荣誉证书与资质文件。以下是平台可核验的公开信息,未上传项如实标注,不做推断。

  • 营业执照未上传
  • 品牌授权未上传
  • 产品检测报告未上传
会员身份
收费会员
经营身份
原厂
成立年份
2020 年
所在地
上海
收录条目
1865 个
平台核验
平台代管
向品牌方索取资质文件

06品牌与供应商

上海英诺赛图 原厂
InnoCyto

以可信赖的细胞研究试剂,助力科研突破

进入企业主页
1865 本目录条目
产地 / 总部上海市浦东新区
成立年份2020 年
本目录主营生化试剂 / 蛋白与抗体

InnoCyto(上海英诺赛图生物科技有限公司)致力于通过开发高质量细胞分析试剂,加速科学发现进程。公司为研究人员提供细胞层面探索所需的工具,推动免疫学、肿瘤学等多领域的研究创新。 核心团队拥有丰富的行业经验,曾参与全球头部生命科学公司的标杆项目搭建,深刻理解工业界与学术研究的前沿需求。试剂从设计之初即以精确性、一致性、高性能为核心标准,让科学家能把精力集中在最核心的研究工作上。 公司将深厚的科学积累与对品质的严格承诺相结合,力争成为全球研究人员信赖的合作伙伴。产品线覆盖经验证的一抗与二抗、同型对照、生物类似药抗体、重组蛋白、细胞因子、免疫检测试剂盒及配套试剂,并提供重组蛋白/抗体表达与标记偶联服务。

售后与服务

品牌资料由厂商公开信息与授权渠道核对整理;条目参数与价格以最终报价单为准。

引用此条目 产品目录 · 更新于 2026-11-12
科研在线(TeleVM). Anti-Human CD7 Antibody(118801)[EB/OL]. 产品目录, 2026-11-12. https://www.suprotek.cn/products/item/anti-human-cd7-antibody-118801.html.
TeleVM. (2026, November 12). Anti-Human CD7 Antibody(118801). 产品目录. https://www.suprotek.cn/products/item/anti-human-cd7-antibody-118801.html
@misc{biocsp_item_anti_human_cd7_antibody_118801,
  title        = {Anti-Human CD7 Antibody(118801)},
  author       = {{科研在线}},
  year         = {2026},
  howpublished = {产品目录},
  note         = {更新于 2026-11-12,产品目录},
  url          = {https://www.suprotek.cn/products/item/anti-human-cd7-antibody-118801.html}
}

GB/T 7714 用于中文论文与报告;APA 7 用于英文期刊;BibTeX 可直接导入 Zotero、EndNote 或 LaTeX。

许可:CC BY-NC 4.0 · 转载注明来源
获取正式报价

Anti-Human CD7 Antibody

提交后由平台转给品牌方,通常 1 个工作日内联系。不需要注册。